Írland - enska - HPRA (Health Products Regulatory Authority)

hope pharmaceuticals ltd - sodium nitrite - solution for injection - 30 milligram(s)/millilitre - sodium nitrite

Írland - enska - HPRA (Health Products Regulatory Authority)

essential pharmaceuticals limited - clobazam - oral suspension - 1 milligram(s)/millilitre - clobazam

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - yellow fever vaccine 1000 [iu] (17d strain);   - suspension for injection - 1000 iu - active: yellow fever vaccine 1000 [iu] (17d strain)   excipient: alanine calcium chloride dihydrate dibasic sodium phosphate dihydrate histidine hydrochloride lactose monohydrate magnesium sulfate heptahydrate monobasic potassium phosphate potassium chloride sodium chloride sodium hydroxide sorbitol purified water sodium chloride - prevention of yellow fever. vaccination is recommended for: · every person over 9 months of age living or travelling through an endemic area. · non-vaccinated persons moving from an endemic to a potentially receptive non-endemic area. · laboratory workers handling potentially infectious materials. · in order to be officially recognised, the yellow fever vaccination must be administered in an approved vaccination centre and registered on an international certificate. the validity period of the certificate is established according to international health regulations recommendations and starts 10 days after primary vaccination and immediately after re-vaccination.

Ísrael - enska - Ministry of Health

sanofi israel ltd - yellow fever virus strain 17d204 (substrain ab237) - powder and solvent for suspension for injection - yellow fever virus strain 17d204 (substrain ab237) - yellow fever, live attenuated - stamaril is indicated for active immunization against yellow fever in persons:• travelling to, passing through or living in an endemic area,• travelling to any country that requires an international certificate of vaccination for entry(which may or may not depend on the previous itinerary).• handling potentially infectious materials (e.g. laboratory personnel).see sections 4.2, 4.3 and 4.4 regarding the minimum age for vaccination of children under special circumstances and guidance for vaccination of other specific patient populations.in order to comply with vaccine regulations and to be officially recognized, yellow fever vaccines must be administered in an approved world health organization (who) vaccination centre and registered on an international certificate of vaccination. the validity period of thiscertificate is established according to international health regulations (ihr) recommendations, and starts 10 days after primary vaccination and immediately after re-vaccination (see section 4.2).

Filippseyjar - enska - FDA (Food And Drug Administration)

interhealthcare pharmaceuticals, inc.; distributor: marilz pharmaceuticals, inc. - omeprazole - capsule - 20 mg

Filippseyjar - enska - FDA (Food And Drug Administration)

zuellig pharma corp - yellow fever vaccine - powder for suspension im/sc

Filippseyjar - enska - FDA (Food And Drug Administration)

zuellig pharma corp - yellow fever vaccine - powder for suspension im/sc

Írland - enska - HPRA (Health Products Regulatory Authority)

sanofi pasteur msd ltd - yellow fever virus 17 d-204 strain - suspension for injection - 1000 - yellow fever vaccines

Malta - enska - Medicines Authority

sanofi pasteur 14 espace henry vallée , 69007 lyon, france - yellow fever, virus strain, d - powder and solvent for suspension for injection - yellow fever virus strain 17d 1000 iu - vaccines

Írland - enska - HPRA (Health Products Regulatory Authority)

sanofi pasteur - yellow fever virus 17 d-204 strain - powder and solvent for suspension for injection in pre-filled syringe - 1000 international unit(s) - yellow fever vaccines; yellow fever, live attenuated